EM Imaging Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Out of Business
- Investors
-
1
EM Imaging General Information
Description
Developer of a molecular targeting technology designed to create a disease-focused approach to optical tracer and therapeutic compound development. The company's technology creates small molecules and peptides that, when conjugated with radionuclides or fluorescent dyes, target specifically cancerous cells and other diseased tissues, enabling healthcare professionals to detect and treat diseases in real-time during interventional procedures, including surgery and provide accurate treatment while sparing healthy tissue.
Contact Information
Website
www.emimaging.comCorporate Office
- 9 Little France Road
- Edinburgh BioQuarter (Gate 3)
- Edinburgh EH16 4UX
- Scotland, United Kingdom
Corporate Office
- 9 Little France Road
- Edinburgh BioQuarter (Gate 3)
- Edinburgh EH16 4UX
- Scotland, United Kingdom
EM Imaging Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 26-Aug-2025 | Completed | Out of Business | |||
| 12. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 11. Later Stage VC | 07-Nov-2019 | Completed | Clinical Trials - Phase 2 | |||
| 10. Early Stage VC (Series A) | 21-May-2018 | Completed | Clinical Trials - Phase 1 | |||
| 9. Grant | 01-Dec-2017 | Completed | Clinical Trials - Phase 1 | |||
| 8. Early Stage VC | 26-May-2017 | Completed | Clinical Trials - Phase 1 | |||
| 7. Early Stage VC (Series A) | 25-Jul-2016 | Completed | Clinical Trials - Phase 1 | |||
| 6. Early Stage VC (Series A) | 01-Apr-2016 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | 01-Mar-2016 | $214K | $9.4M | Completed | Clinical Trials - Phase 1 | |
| 4. Grant | 15-Dec-2015 | $50.5K | $9.4M | Completed | Clinical Trials - Phase 1 |
EM Imaging Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Preferred |
EM Imaging Comparisons
Industry
Financing
Details
EM Imaging Competitors (7)
One of EM Imaging’s 7 competitors is Blue Earth Diagnostics, a Formerly VC-backed company based in Oxford, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Blue Earth Diagnostics | Formerly VC-backed | Oxford, United Kingdom | ||||
| SurgiMab | Venture Capital-Backed | Montpellier, France | ||||
| Fusion Pharmaceuticals | Formerly VC-backed | Hamilton, Canada | ||||
| Advanced Accelerator Applications | Formerly VC-backed | Rueil-Malmaison, France | ||||
| On Target Laboratories | Venture Capital-Backed | West Lafayette, IN |
EM Imaging Patents
EM Imaging Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202315697-D0 | Compounds and methods of use | Inactive | 13-Oct-2023 | ||
| GB-202212937-D0 | Compounds and methods of use | Inactive | 05-Sep-2022 | ||
| GB-202004360-D0 | Compounds and methods of use | Inactive | 26-Mar-2020 | ||
| CA-3142866-A1 | Compound comprising a cmet binding cyclic peptide for human or animal administration and uses thereof | Pending | 14-Jun-2019 | ||
| AU-2020291197-A1 | Compounds and methods of use | Active | 14-Jun-2019 | A61K51/088 |
EM Imaging Signals
EM Imaging Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The University of Edinburgh | University |
EM Imaging FAQs
-
When was EM Imaging founded?
EM Imaging was founded in 2014.
-
Where is EM Imaging headquartered?
EM Imaging is headquartered in Edinburgh, United Kingdom.
-
What is the size of EM Imaging?
EM Imaging has 7 total employees.
-
What industry is EM Imaging in?
EM Imaging’s primary industry is Drug Discovery.
-
Is EM Imaging a private or public company?
EM Imaging is a Private company.
-
What is EM Imaging’s current revenue?
The current revenue for EM Imaging is .
-
How much funding has EM Imaging raised over time?
EM Imaging has raised $22M.
-
Who are EM Imaging’s investors?
The University of Edinburgh has invested in EM Imaging.
-
Who are EM Imaging’s competitors?
Blue Earth Diagnostics, SurgiMab, Fusion Pharmaceuticals, Advanced Accelerator Applications, and On Target Laboratories are some of the 7 competitors of EM Imaging.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process